Early Trials Of Chinese Company's Vaccine Show It Triggers An Immune Response
Hundreds of thousands of people in China have already received this vaccine. Now, preliminary trials are showing promising results, although it's too early to say whether it can prevent disease.
As companies around the world race to develop coronavirus vaccines, hundreds of thousands of with a vaccine before its efficacy was proven in trials. Now, researchers have released preliminary results that show the vaccine produces an immune response, although it's too early to say whether it can prevent disease.
